Khalil Aly Bernard, Dina Roberto, Meeran Karim, Bakir Ali M, Naqvi Saf, Al Tikritti Alia, Lessan Nader, Barakat Maha T
Imperial College London Diabetes Center, Abu Dhabi, United Arab Emirates.
Hammersmith Hospital, London, United Kingdom.
Eur Thyroid J. 2018 Jan;7(1):39-43. doi: 10.1159/000484600. Epub 2017 Nov 21.
Fine needle aspiration (FNA) cytology fails to provide a conclusive diagnosis in a subset of thyroid lesions labeled as "indeterminate" (Thy3). In this study, we aimed at ascertaining the prevalence of Thy3 thyroid nodules in a hitherto unreported ethnic group (residents of the United Arab Emirates).
We retrospectively examined 688 FNA of the thyroid performed on 584 patients. Samples were reported using the Royal College of Physicians' (RCP) Thy classification. The results of the FNA were correlated with the final surgical specimens. Ultrasonography (US) risk stratification was calculated using a web-based US risk of malignancy calculator.
Overall sample adequacy was 97%. The indeterminate group Thy3 was found in 7% of the samples. The overall risk of malignancy in the Thy3 category was 20%. This risk was very similar in the 2 subgroups of Thy3 (17% in Thy 3a and 22% in Thy3f). Subdividing the Thy3 group into subgroups becomes less necessary if the US scoring is <24.5% since the negative predictive value, in this case, is 100%. Applying this criterion to our population would have had the potential of reducing the percentage of patients referred to surgery from 61 to 43%.
Proper risk stratification of Thy3 lesions should be based on the combined risk assessment of clinical, cytological, radiological, and molecular data. Such a pragmatic approach is expected to reduce the percentage of inappropriate referrals to surgery.
细针穿刺(FNA)细胞学检查无法对一部分被标记为“不确定”(Thy3)的甲状腺病变做出明确诊断。在本研究中,我们旨在确定一个此前未报道过的种族群体(阿拉伯联合酋长国居民)中Thy3甲状腺结节的患病率。
我们回顾性检查了对584例患者进行的688次甲状腺FNA。样本报告采用皇家内科医师学院(RCP)的甲状腺分类。FNA结果与最终手术标本相关。使用基于网络的超声恶性风险计算器计算超声(US)风险分层。
总体样本充足率为97%。在7%的样本中发现了不确定组Thy3。Thy3类别的总体恶性风险为20%。在Thy3的两个亚组中,这种风险非常相似(Thy3a为17%,Thy3f为22%)。如果超声评分<24.5%,将Thy3组再细分为亚组就不那么必要了,因为在这种情况下,阴性预测值为100%。将这一标准应用于我们的人群,有可能将转诊至手术的患者比例从61%降至43%。
对Thy3病变进行适当的风险分层应基于临床、细胞学、放射学和分子数据的综合风险评估。这种务实的方法有望减少不适当转诊至手术的患者比例。